Literature DB >> 9494419

Resection of colorectal liver metastases: 25-year experience.

B Ohlsson1, U Stenram, K G Tranberg.   

Abstract

The aim of this retrospective study was to analyze survival and prognostic factors in 111 consecutive patients undergoing curative resection of liver metastases from colorectal cancer. In addition, the time periods 1971-1984 and 1985-1995 were compared; criteria for first liver resection did not change with time, whereas the attitude toward re-resection was more aggressive during the latter period. Operative mortality was 6% during 1971-1984 and 0% during 1985-1995 (3.6% for all patients). The crude 5-year actuarial survivals were 19% and 35% for patients operated during 1971-1984 and 1985-1995, respectively (25% for the whole period). Relapse at any site was observed in 52 patients (81%) operated during the first period and in 29 patients (67%) operated during the second period; re-resection was performed in 12 (23%) and 15 (52%) of these patients, respectively. Five-year survival after hepatic re-resection was 29% (no operative mortality). In the univariate analysis, significant determinants for long-term survival were, in descending order, a clear resection margin, high degree of fibrosis around the tumor, absence of extrahepatic metastases (including metastases to the liver hilum), use of an ultrasound dissector, low preoperative serum carcinoembryonic antigen (CEA) level, year of resection (1985-1995), and low/moderate grade of liver tumor. There were no 5-year survivors when extrahepatic metastases were present, the liver tumor(s) had a low differentiation or satellites, or the resection margin was involved with tumor. In the multivariate analysis, the determinants were grade of liver tumor, absence of extrahepatic tumor, few intraoperative blood transfusions, low preoperative serum CEA level, and year of resection (1985-1995). It is concluded that: (1) an increased rate of hepatic re-resection was partly responsible for the improved outcome after liver resection for colorectal metastases during recent years; (2) patients with extrahepatic metastases did not benefit from liver resection; and (3) surgery should be performed with a clear resection margin and minimal blood loss.

Entities:  

Mesh:

Year:  1998        PMID: 9494419     DOI: 10.1007/s002689900381

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  48 in total

Review 1.  [Liver metastases. Diagnosis and therapy].

Authors:  R Konopke; H D Saeger
Journal:  Chirurg       Date:  2003-09       Impact factor: 0.955

2.  Colorectal Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

3.  Complications following liver resection for colorectal metastases do not impact on longterm outcome.

Authors:  Tony C Pang; Calista Spiro; Tim Ramacciotti; Julian Choi; Martin Drummond; Edmund Sweeney; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2014-08-26       Impact factor: 3.647

4.  Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer.

Authors:  Wolfgang Peter Fendler; Harun Ilhan; Philipp M Paprottka; Tobias F Jakobs; Volker Heinemann; Peter Bartenstein; Feras Khalaf; Samer Ezziddin; Marcus Hacker; Alexander R Haug
Journal:  Eur Radiol       Date:  2015-02-28       Impact factor: 5.315

5.  Role of Ultrasonography in the Surveillance of Disease-Free Patients with Colorectal Cancer: a Retrospective Audit.

Authors:  Garima Suman; Akshay D Baheti; Suman Kumar Ankathi; Nitin Shetty; Suyash Kulkarni; Vikas Ostwal; Avanish P Saklani
Journal:  Indian J Surg Oncol       Date:  2018-09-04

6.  Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.

Authors:  Norifumi Hattori; Yukihide Kanemitsu; Koji Komori; Yasuhiro Shimizu; Tsuyoshi Sano; Yoshiki Senda; Tetsuya Mitsudomi; Takayuki Fukui
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 7.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

8.  Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance.

Authors:  Hartwig Körner; Kjetil Söreide; Pål J Stokkeland; Jon Arne Söreide
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

9.  Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Mitsuyoshi Ohta; Shinji Togo; Shuji Saitou; Shigeki Yamaguchi; Itaru Endo; Hitoshi Sekido
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

10.  Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.

Authors:  Narendra Battula; Dimitrios Tsapralis; David Mayer; John Isaac; Paolo Muiesan; Robert P Sutcliffe; Simon Bramhall; Darius Mirza; Ravi Marudanayagam
Journal:  HPB (Oxford)       Date:  2013-03-27       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.